2296
HR 3590 EAS/PP
recommendation of the Board will not be imple-
1
mented, such Director shall provide an expla-
2
nation of the reasons for not implementing such
3
recommendation.
4
``(5) M
EETINGS
.--
5
``(A) I
N GENERAL
.--The Board shall meet 4
6
times per calendar year, at the call of the Chair-
7
person.
8
``(B) Q
UORUM
;
REQUIREMENTS
;
LIMITA
-
9
TIONS
.--
10
``(i) Q
UORUM
.--A quorum shall consist
11
of a total of 13 members of the Board, ex-
12
cluding ex-officio members, with diverse
13
representation as described in clause (iii).
14
``(ii) C
HAIRPERSON
OR
VICE
CHAIR
-
15
PERSON
.--Each meeting of the Board shall
16
be attended by either the Chairperson or the
17
Vice Chairperson.
18
``(iii) D
IVERSE REPRESENTATION
.--At
19
each meeting of the Board, there shall be not
20
less than one scientist, one representative of
21
a disease advocacy organization, and one
22
representative of a professional venture cap-
23
ital or private equity organization.
24
``(6) C
OMPENSATION AND TRAVEL EXPENSES
.--
25